CG Oncology, Inc. Common stock

CGON

CGONCG Oncology, Inc. Common stock US flag

NASDAQ Global Select

56.37

USD

+0.84

- -

4.97BMarket Cap

Income Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	10	- -	- -	1	4
+ Sales & Services Revenue	10	- -	- -	1	4
- Cost of Revenue	- -	- -	- -	- -	5
+ Cost of Goods & Services	- -	- -	- -	- -	5
Gross Profit	- -	- -	- -	1	-1
+ Other Operating Income	-10	- -	- -	- -	- -
- Operating Expenses	23	35	56	116	190
+ Selling, General & Admin	5	6	10	34	74
+ Research & Development	18	29	46	82	117
+ Other Operating Expense	- -	- -	- -	- -	- -
Operating Income (Loss)	-13	-35	-55	-115	-191
- Non-Operating (Income) Loss	- -	- -	-7	-27	-30
+ Interest Expense, Net	- -	- -	-7	-27	-30
+ Interest Expense	- -	- -	- -	- -	- -
- Interest Income	- -	- -	7	27	30
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	- -
Pretax Income	-13	-35	-49	-88	-161
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-13	-35	-49	-88	-161
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-13	-35	-49	-88	-161
- Minority Interest	- -	- -	- -	- -	- -
Net Income, GAAP	-13	-35	-49	-88	-161
- Preferred Dividends	6	8	19	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-18	-44	-68	-88	-161
EBIT	-13	-35	-55	-115	-191
EBITDA	-13	-35	-55	-115	-189
EBITDA Margin (%)	-121.61	-18,445.55	-27,172.55	-10,064.44	-4,686.36
EBITA	-13	-35	-55	-115	-191
Gross Margin (%)	100	100	100	100	-15.02
Operating Margin (%)	-121.7	-18,453.4	-27,180.88	-10,067.25	-4,722.13
Profit Margin (%)	-123.95	-18,556.54	-23,826.96	-7,729.5	-3,985.02
Sales per Employee	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	1
Basic Weighted Avg Shares	34	4	4	62	- -
Basic EPS, GAAP	-0.55	-11.71	-15.65	-1.41	- -
Basic EPS from Cont Ops	-0.38	-9.47	-11.22	-1.41	- -
Diluted Weighted Avg Shares	34	4	4	62	- -
Diluted EPS, GAAP	-0.55	-11.71	-15.65	-1.41	- -
Diluted EPS from Cont Ops	-0.38	-9.47	-11.22	-1.41	- -

Balance Sheet (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	58	147	194	754	759
+ Cash, Cash Equivalents & STI	54	143	188	742	742
+ Cash & Cash Equivalents	54	88	8	257	32
+ ST Investments	- -	55	179	485	710
+ Accounts & Notes Receiv	- -	- -	- -	- -	1
+ Accounts Receivable, Net	- -	- -	- -	- -	1
+ Notes Receivable, Net	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	2
+ Raw Materials	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	2
+ Other ST Assets	5	3	6	12	15
+ Misc ST Assets	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	1	5	1	32
+ Property, Plant & Equip, Net	- -	1	- -	- -	20
+ Property, Plant & Equip	- -	1	- -	1	21
- Accumulated Depreciation	- -	- -	- -	- -	1
+ LT Investments & Receivables	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	5	- -	13
+ Total Intangible Assets	- -	- -	- -	- -	11
+ Goodwill	- -	- -	- -	- -	10
+ Other Intangible Assets	- -	- -	- -	- -	1
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	5	- -	2
Total Assets	59	148	199	755	792
+ Payables & Accruals	2	4	10	15	21
+ Accounts Payable	1	1	3	7	6
+ Accrued Taxes	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -
+ Other Payables & Accruals	1	3	7	8	15
+ ST Debt	3	9	- -	- -	1
+ ST Borrowings	3	9	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	1
+ Other ST Liabilities	1	2	4	6	9
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Misc ST Liabilities	1	2	4	6	9
Total Current Liabilities	6	15	14	21	31
+ LT Debt	12	7	- -	- -	6
+ LT Borrowings	12	7	- -	- -	3
+ LT Finance Leases	- -	- -	- -	- -	3
+ Other LT Liabilities	- -	- -	- -	- -	2
+ Accrued Liabilities	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -	- -	2
Total Noncurrent Liabilities	12	7	- -	- -	8
Total Liabilities	18	23	15	21	39
+ Preferred Equity and Hybrid Capital	83	203	308	- -	- -
+ Share Capital & APIC	3	4	7	951	1,132
+ Common Stock	- -	- -	- -	- -	- -
+ Additional Paid in Capital	3	4	7	951	1,132
- Treasury Stock	- -	- -	- -	- -	- -
+ Retained Earnings	-46	-81	-130	-218	-379
+ Other Equity	- -	- -	- -	- -	- -
Equity Before Minority Interest	40	125	185	733	753
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
Total Equity	40	125	185	733	753
Total Liabilities & Equity	59	148	199	755	792
Shares Outstanding	63	63	63	76	81
Number of Employees	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	4
Net Debt	-39	-73	-8	-257	-29
Net Debt to Equity	-95.9	-58.03	-4.47	-35.05	-3.92
Tangible Common Equity Ratio	-72.61	-52.59	-61.77	97.16	95.01
Current Ratio	9.78	9.54	13.62	35.3	24.63
Cash Conversion Cycle	- -	- -	- -	- -	-266.79

Cash Flow Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-13	-35	-49	-88	-161
+ Depreciation & Amortization	- -	- -	- -	- -	1
+ Non-Cash Items	1	1	-1	6	25
+ Stock-Based Compensation	1	1	2	11	27
+ Deferred Income Taxes	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	1	-2	-5	-2
+ Chg in Non-Cash Work Cap	-2	4	3	3	2
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-2	1	-3	-6	-2
+ Inc (Dec) in Accts Payable	- -	3	6	9	7
+ Inc (Dec) in Other	- -	- -	- -	- -	-2
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Operating Activities	-14	-30	-46	-79	-132
+ Change in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	629	147
+ Increase in Capital Stock	- -	- -	- -	629	147
+ Decrease in Capital Stock	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	-55	-121	-301	-224
+ Dec in LT Investment	- -	- -	396	745	844
+ Inc in LT Investment	- -	-55	-518	-1,046	-1,068
+ Net Cash From Acq & Div	- -	- -	- -	- -	-22
+ Cash from Divestitures	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	-22
+ Cash for JVs	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	-55	-121	-301	-246
+ Dividends Paid	- -	- -	- -	- -	- -
+ Net Cash From Debt	15	- -	-16	- -	- -
+ Cash From Debt	15	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	-16	- -	- -
+ Other Financing Activities	- -	120	103	-1	6
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Financing Activities	15	120	87	628	154
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -
Net Changes in Cash	2	35	-80	249	-225
EBITDA	-13	-35	-55	-115	-189
EBITDA Margin (%)	-121.61	-18,445.55	-27,172.55	-10,064.44	-4,686.36
Free Cash Flow	-14	-30	-46	-79	-132
Net Cash Paid for Acquisitions	- -	- -	- -	- -	22
Free Cash Flow to Firm	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	82	24	-387	-132
Free Cash Flow per Basic Share	-0.41	-7.97	-10.55	-1.26	- -
Price/Free Cash Flow	- -	- -	- -	-22.84	- -
Cash Flow to Net Income	1.06	0.84	0.94	0.89	0.82
Capital Expenditures	- -	- -	- -	- -	- -